Patents by Inventor Robert Edward KEARNEY

Robert Edward KEARNEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and system for determining optimal and recommended therapy parameters for diabetic subject
    Patent number: 11931548
    Abstract: There is provided a method and a system for determining recommended multiple daily injections (MDI) therapy values for administering to a given subject. Consumed meals, insulin basal doses administered and insulin bolus doses administered to the given subject are received. An initial meal ratio parameter and an initial basal insulin dose used by the given subject are received. A predicted glucose concentration parameter is determined based on the consumed meals, the insulin basal dose, the insulin bolus doses, and the initial meal ratio parameter. An actual glucose concentration parameter is received. A set of optimal MDI therapy parameters are estimated using the predicted glucose concentration parameter, and the actual glucose concentration parameter.
    Type: Grant
    Filed: August 26, 2020
    Date of Patent: March 19, 2024
    Inventors: Anas El Fathi, Ahmad Haidar, Robert Edward Kearney
  • METHOD AND SYSTEM FOR DETERMINING OPTIMAL AND RECOMMENDED THERAPY PARAMETERS FOR DIABETIC SUBJECT
    Publication number: 20220062544
    Abstract: There is provided a method and a system for determining recommended multiple daily injections (MDI) therapy values for administering to a given subject. Consumed meals, insulin basal doses administered and insulin bolus doses administered to the given subject are received. An initial meal ratio parameter and an initial basal insulin dose used by the given subject are received. A predicted glucose concentration parameter is determined based on the consumed meals, the insulin basal dose, the insulin bolus doses, and the initial meal ratio parameter. An actual glucose concentration parameter is received. A set of optimal MDI therapy parameters are estimated using the predicted glucose concentration parameter, and the actual glucose concentration parameter.
    Type: Application
    Filed: August 26, 2020
    Publication date: March 3, 2022
    Inventors: Anas EL FATHI, Ahmad HAIDAR, Robert Edward KEARNEY